🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.

Some experts said the demand for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, risking fines, prosecution or prison.

Platform Reaction and Material Elimination

According to TikTok, the service has removed problematic material and prohibited associated keywords and query recommendations. The organization stated it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with images of weight loss, positive reviews and step-by-step guides for mixing or administering at residence.

After minutes of joining one community, a seller shared contact information, where most transactions occur. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.

Item Details and Costs

Inside these groups, messages show dark colored packages with postal service labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service stated it regularly monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously seen patients injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.